Canopy Partners’s Amgen AMGN Stock Holding History

Canopy Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	4,519 -55	-1%	-$18.8K	0.49%	44
2026 Q1	$1.61M	Buy	4,574 +8	+0.2%	+$2.85K	0.55%	36
2025 Q4	$1.49M	Buy	4,566 +183	+4%	+$58K	0.49%	43
2025 Q3	$1.24M	Buy	4,383 +117	+3%	+$33.9K	0.41%	53
2025 Q2	$1.19M	Sell	4,266 -13	-0.3%	-$3.68K	0.44%	50
2025 Q1	$1.33M	Buy	4,279 +50	+1%	+$14.8K	0.52%	41
2024 Q4	$1.1M	Buy	4,229 +1,662	+65%	+$493K	0.42%	49
2024 Q3	$827K	Buy	2,567 +6	+0.2%	+$1.96K	0.36%	63
2024 Q2	$800K	Buy	2,561 +31	+1%	+$9.11K	0.37%	60
2024 Q1	$719K	Buy	2,530 +63	+3%	+$18.4K	0.35%	70
2023 Q4	$711K	Buy	+2,467	New	+$672K	0.43%	51

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Canopy Partners's AMGN Position: Q2 2026 in Review

Canopy Partners reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $18.8K and leaving 4,519 shares worth $1.64M. The position accounts for 0.49% of the portfolio, ranked #44.

Canopy Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 985 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Canopy Partners held 4,519 shares of Amgen worth $1.64M as of Q2 2026.
Canopy Partners sold 55 Amgen shares in Q2 2026, an estimated $18.8K.
Amgen made up 0.49% of Canopy Partners's portfolio in Q2 2026, its #44 holding.
Canopy Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
985 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.